Status:
COMPLETED
Colorectal Cancer Screening in Average-risk Population: Immunochemical Fecal Occult Blood Testing Versus Colonoscopy
Lead Sponsor:
Hospital Clinic of Barcelona
Collaborating Sponsors:
Fundacion Cientifica de la Asociacion Española contra el Cancer
Instituto de Salud Carlos III
Conditions:
Colorectal Cancer
Colorectal Neoplasm
Eligibility:
All Genders
50-69 years
Phase:
NA
Brief Summary
Aims: 1. To compare the efficacy of biennial immunochemical fecal occult blood test (iFOBT) versus colonoscopy every 10 years for the reduction of colorectal cancer-related mortality at 10 years in a...
Eligibility Criteria
Inclusion
- Men and women aged 50-69 years
Exclusion
- Personal history of colorectal cancer, colorectal adenoma, colorectal polyposis, or inflammatory bowel disease
- Family history of colorectal polyposis, Lynch syndrome or familial colorectal cancer (2 or more first-degree relatives diagnosed with colorectal cancer or one first-degree relative diagnosed with colorectal cancer before the age of 60)
- Severe comorbidity
- Previous total colectomy
- Not signed informed consent to participate
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
55498 Patients enrolled
Trial Details
Trial ID
NCT00906997
Start Date
November 1 2008
End Date
December 31 2021
Last Update
March 18 2025
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital del Mar
Barcelona, Spain
2
Hospital Clínico
Madrid, Spain
3
Hospital Universitario Virgen de la Arrixaca
Murcia, Spain
4
Hospital Meixoeiro
Ourense, Spain